Objective To investigate the effect of intermittent androgen blockade (IAB) on the quality of
life (QOL) of patients with advanced prostatic carcinoma (APC). Methods Investigations on …

Purpose: To compare the efficacy, quality of life (QoL) and side effects of intermittent
androgen blockade (IAB) vs. continuous androgen blockade (CAB) as treatment of …

Objective To evaluate the health-related quality of life (HRQOL) for prostate cancer patients
receiving androgen deprivation therapy (ADT). Methods We studied 200 patients with …

Materials and Methods Between January 2006 and May 2015, 603 patients were selected
and divided into continuous ADT (CADT)(n= 175) and intermittent ADT (IADT)(n= 428) …

PURPOSE: The goal of intermittent androgen deprivation (IAD) therapy in prostate cancer
patients is to delay the disease progression and improve the survival rate. Therefore, the …

Objective To investigate the effect of intermittent hormonal therapy (IHT) for patients with
different stage/grade prostate cancer (PCa). Methods The number of cycles and the duration …

In 1941, Huggins and Hodges [9] introduced the permanent androgen withdrawal as first-
line treatment for advanced cancer of the prostate (CaP). At present this is still the standard …

OBJECTIVES: To clarify the effect of intermittent androgen suppression on the time to
androgen-independent progression and changes in quality of life (QOL). METHODS …

Objective: We evaluated health‐related quality of life (HRQOL) in Japanese men receiving
androgen deprivation therapy (ADT) for prostate cancer. Methods: Fifty‐six men were …

At present androgen ablation therapy is the therapy of choice for the treatment of metastatic
prostate cancer. However, in more than 50% of the patients the disease will ultimately …